Cargando…
Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in Catalonia
To assess the clinical characteristics, the prescription pattern of GLP-1 receptor agonists (GLP-1RA) users, and HbA1c and weight change, we retrospectively assessed patients with type 2 diabetes by initiating GLP-1RA as an add-on to the standard of care in Catalonia. The mean change from the baseli...
Autores principales: | Franch-Nadal, Josep, Mata-Cases, Manel, Ortega, Emilio, Real, Jordi, Gratacòs, Mònica, Vlacho, Bogdan, Vallés, Joan Antoni, Mauricio, Dídac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780172/ https://www.ncbi.nlm.nih.gov/pubmed/31491916 http://dx.doi.org/10.3390/jcm8091389 |
Ejemplares similares
-
Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007–2018
por: Mata-Cases, Manel, et al.
Publicado: (2022) -
Cardiovascular and mortality benefits of sodium–glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus: CVD-Real Catalonia
por: Real, Jordi, et al.
Publicado: (2021) -
Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia
por: Giménez-Pérez, Gabriel, et al.
Publicado: (2023) -
How Many Patients with Type 2 Diabetes Meet the Inclusion Criteria of the Cardiovascular Outcome Trials with SGLT2 Inhibitors? Estimations from a Population Database in a Mediterranean Area
por: Canivell, Silvia, et al.
Publicado: (2019) -
Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain)
por: Gimenez-Perez, Gabriel, et al.
Publicado: (2021)